Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01797822 · ClinicalTrials.gov registry record · Phase 4
Effects of Dry Eye Treatments on the Ocular Surface
A Phase 4 study of Dry Eye Syndrome and Keratoconjunctivitis Sicca, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01797822 is a Phase 4 study of Dry Eye Syndrome and Keratoconjunctivitis Sicca that has completed, run by Baylor College of Medicine. The registered enrollment target is 20 participants, below the 163-participant average among 10 other Dry Eye Syndrome trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01797822, a Phase 4 study of Dry Eye Syndrome and Keratoconjunctivitis Sicca, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate whether, in people with dry eye syndrome, over the counter artificial tears and the prescription eye drop, dexamethasone, change or effect the eyes response to a low humidity environment. It is known that irritation from dry eye can be improved by over the counter artificial tears because they wet and lubricate the eyes. The prescription eye drop, dexamethasone, can also improve eye irritation by decreasing the inflammation that develops in dry eye. Thus, the investigators hypothesize that the use of these conventional dry eye treatments will improve the eyes' response to a low humidity environment.
Conditions Studied
Interventions
- DRUG Dexamethasone
- DRUG Artificial tear
Study Locations (1)
Texas
- Baylor College of Medicine, Alkek Eye Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01797822
The ClinicalTrials.gov registry entry for NCT01797822 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 163-participant average among 10 other Dry Eye Syndrome trials with a reported enrollment target (88% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Dry Eye Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Dexamethasone is the first listed.
NCT01797822 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01797822 about?
NCT01797822 is a clinical study titled "Effects of Dry Eye Treatments on the Ocular Surface". The purpose of this study is to evaluate whether, in people with dry eye syndrome, over the counter artificial tears and the prescription eye drop, dexamethasone, change or effect the eyes response to a low humidity environment. It is known that irritation from dry eye can be improved by over the c...
What is the current status of trial NCT01797822?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2013-02. Estimated completion is 2015-12.
What conditions does trial NCT01797822 study?
This clinical trial studies the following conditions: Dry Eye Syndrome, Keratoconjunctivitis Sicca.
What interventions are being tested in trial NCT01797822?
The interventions under investigation include: Dexamethasone (DRUG), Artificial tear (DRUG).
Who is sponsoring clinical trial NCT01797822?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01797822 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)
RECRUITING · Phase 1
-
Oral Omega-3 Fatty Acids in the Treatment of Dry Eye Syndrome
COMPLETED · NA
-
Study of SkQ1 as Treatment for Dry-eye Syndrome
COMPLETED · Phase 3
-
Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye
COMPLETED · Phase 2
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
COMPLETED · Phase 1
-
Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.